Catalyst Wire Dossier Catalyst Wire Dossier

Irinotecan liposome injection

irinotecan liposome injection · CSPC Ouyi Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Irinotecan liposome injection, covering 2024-03-13 to 2024-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas [Phase 2]

See pricing